T1	DISO 592 598	crisis
#1	AnnotatorNotes T1	C0231224; Crisis; Finding
T2	DISO 69 97	cefalea en racimos episódica
#2	AnnotatorNotes T2	C0393739; Episodic Cluster Headache; Disease or Syndrome
T3	PROC 118 187	Estudio de fase III aleatorizado, doble ciego, controlado con placebo
T4	DISO 219 247	cefalea en racimos episódica
#3	AnnotatorNotes T4	C0393739; Episodic Cluster Headache; Disease or Syndrome
T5	DISO 269 297	Cefalea en Racimos Episódica
#4	AnnotatorNotes T5	C0393739; Episodic Cluster Headache; Disease or Syndrome
T6	DISO 373 399	cefalea en racimos crónica
#5	AnnotatorNotes T6	C0009088; chronic cluster headache; Disease or Syndrome
T7	DISO 417 423	crisis
#6	AnnotatorNotes T7	C0231224; Crisis; Finding
T8	PROC 465 471	tratar
#7	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	DISO 602 620	cefalea en racimos
#8	AnnotatorNotes T9	C0009088; Cluster Headache; Disease or Syndrome
T10	DISO 639 647	cefaleas
#9	AnnotatorNotes T10	C0018681; Headache; Sign or Symptom
T11	PROC 765 779	ensayo clínico
#10	AnnotatorNotes T11	C0008976; Clinical Trials; Research Activity
T12	CHEM 807 814	fármaco
#11	AnnotatorNotes T12	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T13	CHEM 935 945	anticuerpo
#12	AnnotatorNotes T13	C0003241; Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T14	CHEM 956 968	péptido CGRP
#13	AnnotatorNotes T14	C0006669; Calcitonin Gene-Related Peptide; Amino Acid, Peptide, or Protein · Hormone
T15	CHEM 977 987	anticuerpo
#14	AnnotatorNotes T15	C0003241; Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T16	CHEM 1021 1031	anticuerpo
#15	AnnotatorNotes T16	C0003241; Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T17	CHEM 1042 1072	factor de crecimiento nervioso
#16	AnnotatorNotes T17	C0027752; nerve growth factor; Amino Acid, Peptide, or Protein · Biologically Active Substance | C0027754; Nerve Growth Factors; Amino Acid, Peptide, or Protein · Biologically Active Substance
T18	CHEM 1074 1077	NGF
#17	AnnotatorNotes T18	C0027752; nerve growth factor; Amino Acid, Peptide, or Protein · Biologically Active Substance | C0027754; Nerve Growth Factors; Amino Acid, Peptide, or Protein · Biologically Active Substance
T19	CHEM 1100 1112	indometacina
#18	AnnotatorNotes T19	C0021246; indomethacin; Organic Chemical · Pharmacologic Substance
T20	DISO 1141 1181	cefalalgia neurovegetativa del trigémino
#19	AnnotatorNotes T20	C1565172; trigeminal autonomic cephalalgia; Disease or Syndrome
T21	DISO 1243 1250	migraña
#20	AnnotatorNotes T21	C0149931; Migraine Disorders; Disease or Syndrome
T22	DISO 1287 1295	isquemia
#21	AnnotatorNotes T22	C0022116; Ischemia; Pathologic Function
T23	DISO 1321 1338	Hipersensibilidad
#22	AnnotatorNotes T23	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T24	CHEM 1377 1401	anticuerpos monoclonales
#23	AnnotatorNotes T24	C0003250; Monoclonal Antibodies; Amino Acid, Peptide, or Protein · Immunologic Factor
T25	CHEM 1410 1432	proteínas terapéuticas
#24	AnnotatorNotes T25	C0872285; therapeutic protein; Pharmacologic Substance
T26	DISO 1465 1482	enfermedad médica
T27	DISO 1497 1512	problema médico
T28	DISO 1577 1600	enfermedad psiquiátrica
#25	AnnotatorNotes T28	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T29	CHEM 192 201	LY2951742
#26	AnnotatorNotes T29	C4742733; LY2951742; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T30	DISO 519 524	dolor
#27	AnnotatorNotes T30	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T31	CHEM 998 1015	receptor del CGRP
#28	AnnotatorNotes T31	C0108066; Calcitonin-Gene Related Peptide Receptor; Amino Acid, Peptide, or Protein · Receptor
T32	ANAT 1152 1167	neurovegetativa
#29	AnnotatorNotes T32	C0004388; Autonomic nervous system; Body System
T33	ANAT 1172 1181	trigémino
#30	AnnotatorNotes T33	C1305908; Entire trigeminal nerve; Body Part, Organ, or Organ Component
T34	CHEM 1351 1375	sustancias farmacéuticas
#31	AnnotatorNotes T34	C1254351; Pharmacologic Substance; Pharmacologic Substance
T35	Date 12 16	2015
T36	LIVB 55 64	pacientes
#32	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	LIVB 205 214	pacientes
#33	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 342 351	pacientes
#34	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Duration 392 399	crónica
#35	AnnotatorNotes T39	C0205191; chronic; Temporal Concept
T40	Duration 432 459	los últimos 7 dias a un año
T42	Neg_cue 461 464	sin
T43	Neg_cue 510 518	libre de
T44	Duration 528 534	≥1 mes
T45	LIVB 555 564	pacientes
#36	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Date 694 710	en la actualidad
T47	Duration 750 761	los 30 días
T49	Date 895 911	en la actualidad
T50	Spec_cue 1115 1122	posible
T53	Spec_cue 1563 1576	sugestivos de
T54	LIVB 1650 1662	investigador
#37	AnnotatorNotes T54	C0035173; Research Personnel; Professional or Occupational Group
T55	LIVB 1666 1711	Mujeres embarazadas o en período de lactancia
#38	AnnotatorNotes T55	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T59	LIVB 325 338	Participantes
#39	AnnotatorNotes T59	C4554048; Study Participant; Population Group
T60	LIVB 538 551	Participantes
#40	AnnotatorNotes T60	C4554048; Study Participant; Population Group
T41	PHYS 1674 1685	embarazadas
#41	AnnotatorNotes T41	C0032961; Pregnancy; Organism Function
T51	PHYS 1702 1711	lactancia
#42	AnnotatorNotes T51	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T48	CHEM 831 874	producto sanitario en fase de investigación
#43	AnnotatorNotes T48	C0013230; Investigational New Drugs; Pharmacologic Substance
A1	Assertion T8 Negated
A2	Assertion T30 Negated
A3	Assertion T20 Speculated
A4	Assertion T28 Speculated
A5	Status T6 History_of
A6	Status T21 History_of
A7	Status T26 History_of
A8	Status T13 History_of
A9	Status T15 History_of
A10	Status T16 History_of
A11	Status T11 History_of
A12	Status T12 History_of
A13	Status T48 History_of
A14	Status T23 History_of
A15	Status T27 History_of
#44	AnnotatorNotes T3	C0282461; Phase 3 Clinical Trials; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product 
#45	AnnotatorNotes T46	C0521116; Current (present time); Temporal Concept 
#46	AnnotatorNotes T49	C0521116; Current (present time); Temporal Concept 
#47	AnnotatorNotes T27	C5441915; Medical problem; Finding
T52	Neg_cue 1517 1523	impida
T56	Observation 1527 1554	participación en el estudio
A16	Assertion T56 Negated
#48	AnnotatorNotes T56	C1278516; Patient participation status; Finding
R1	Negation Arg1:T52 Arg2:T56	
R2	Negation Arg1:T43 Arg2:T30	
R3	Speculation Arg1:T50 Arg2:T20	
T57	Quantifier_or_Qualifier 1182 1199	bien diferenciada
A17	Assertion T57 Speculated
#49	AnnotatorNotes T57	C0205615; Well Differentiated; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T57	
T58	Spec_cue 1255 1261	puedan
A18	Assertion T22 Speculated
R5	Before Arg1:T21 Arg2:T22	
R6	Speculation Arg1:T58 Arg2:T22	
T61	CONC 1298 1309	confundirse
A19	Assertion T61 Speculated
R7	Speculation Arg1:T58 Arg2:T61	
R8	Speculation Arg1:T53 Arg2:T28	
T62	Observation 1601 1610	inestable
A20	Assertion T62 Speculated
#50	AnnotatorNotes T62	C0443343; Unstable status; Finding
R9	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T62	
T63	Quantifier_or_Qualifier 1613 1619	activa
A21	Assertion T63 Speculated
#51	AnnotatorNotes T63	C0679217; Active State; Idea or Concept
R10	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T63	
T64	Quantifier_or_Qualifier 1620 1633	significativa
A22	Assertion T64 Speculated
#52	AnnotatorNotes T64	C0750502; Significant; Idea or Concept
R11	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T64	
R12	Speculation Arg1:T53 Arg2:T62	
R13	Speculation Arg1:T53 Arg2:T63	
R14	Speculation Arg1:T53 Arg2:T64	
T65	Observation 719 729;762 779	abandonado un ensayo clínico
#53	AnnotatorNotes T65	C0422727; Patient withdrawn from trial; Finding (?)
R15	Before Arg1:T65 Arg2:T47	
R16	Has_Duration_or_Interval Arg1:T65 Arg2:T47	
A23	Status T65 History_of
T66	Observation 681 693;730 732;762 779	participando en un ensayo clínico
#54	AnnotatorNotes T66	C1278516; Patient participation status; Finding (?)
R18	Overlap Arg1:T66 Arg2:T46	
R20	Before Arg1:T12 Arg2:T65	
R21	Before Arg1:T48 Arg2:T65	
R22	Before Arg1:T48 Arg2:T47	
R23	Before Arg1:T12 Arg2:T47	
R24	Overlap Arg1:T13 Arg2:T49	
R25	Overlap Arg1:T15 Arg2:T49	
R26	Overlap Arg1:T16 Arg2:T49	
T67	Quantifier_or_Qualifier 946 968	frente al péptido CGRP
A24	Status T67 History_of
R27	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T67	
T68	Quantifier_or_Qualifier 988 1015	frente al receptor del CGRP
A25	Status T68 History_of
R28	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T68	
T69	Quantifier_or_Qualifier 1032 1078	frente al factor de crecimiento nervioso (NGF)
A26	Status T69 History_of
R29	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T69	
R30	Location_of Arg1:T32 Arg2:T20	
R31	Location_of Arg1:T33 Arg2:T20	
T70	Quantifier_or_Qualifier 1215 1226	permanentes
#55	AnnotatorNotes T70	C0205355; Permanent; Temporal Concept
R32	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T70	
A27	Status T70 History_of
R34	Causes Arg1:T34 Arg2:T23	
R35	Causes Arg1:T24 Arg2:T23	
R36	Causes Arg1:T25 Arg2:T23	
#56	AnnotatorNotes T26	C0012634; Disease; Disease or Syndrome (?)
R37	Before Arg1:T26 Arg2:T56	
R38	Before Arg1:T27 Arg2:T56	
R39	Experiences Arg1:T55 Arg2:T41	
R40	Experiences Arg1:T55 Arg2:T51	
R41	Experiences Arg1:T36 Arg2:T2	
R42	Experiences Arg1:T37 Arg2:T29	
R43	Experiences Arg1:T37 Arg2:T4	
R44	Experiences Arg1:T59 Arg2:T6	
R45	Experiences Arg1:T38 Arg2:T6	
R46	Has_Duration_or_Interval Arg1:T6 Arg2:T39	
T71	Quantifier_or_Qualifier 404 416	al menos dos
R47	Causes Arg1:T6 Arg2:T7	
R48	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T71	
R49	Has_Duration_or_Interval Arg1:T7 Arg2:T40	
R50	Negation Arg1:T42 Arg2:T8	
R51	Experiences Arg1:T59 Arg2:T8	
R52	Experiences Arg1:T38 Arg2:T8	
R53	Experiences Arg1:T59 Arg2:T7	
R54	Experiences Arg1:T38 Arg2:T7	
T72	Observation 501 509	remision
#57	AnnotatorNotes T72	C0544452; Disease remission; Finding
R55	Before Arg1:T30 Arg2:T72	
R56	Has_Duration_or_Interval Arg1:T72 Arg2:T44	
R57	Has_Duration_or_Interval Arg1:T30 Arg2:T44	
R59	Before Arg1:T7 Arg2:T72	
R61	Before Arg1:T6 Arg2:T30	
R62	Before Arg1:T7 Arg2:T30	
R63	Experiences Arg1:T59 Arg2:T72	
R64	Experiences Arg1:T59 Arg2:T30	
R65	Experiences Arg1:T38 Arg2:T72	
R66	Experiences Arg1:T38 Arg2:T30	
T73	Quantifier_or_Qualifier 624 638	otros tipos de
R67	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T73	
R68	Experiences Arg1:T60 Arg2:T1	
R69	Experiences Arg1:T60 Arg2:T9	
R70	Experiences Arg1:T60 Arg2:T10	
R71	Experiences Arg1:T45 Arg2:T1	
R72	Experiences Arg1:T45 Arg2:T9	
R73	Experiences Arg1:T45 Arg2:T10	
T74	Observation 566 620	capaces de distinguir las crisis de cefalea en racimos
R74	Has_Quantifier_or_Qualifier Arg1:T60 Arg2:T74	
R75	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T74	
R58	Before Arg1:T6 Arg2:T72	
A28	Experiencer T36 Patient
A29	Experiencer T37 Patient
A30	Experiencer T59 Patient
A31	Experiencer T38 Patient
A32	Experiencer T60 Patient
A33	Experiencer T45 Patient
A34	Experiencer T54 Other
A35	Experiencer T55 Patient
